Medimaging Integrated Solution Inc. (6796) Stock Statistics & Valuation Metrics
Total Valuation
Medimaging Integrated Solution Inc. has a market cap or net worth of TWD 1.99B. The enterprise value is TWD 2.34B.
- Market Cap
- TWD 1.99B
- Enterprise Value
- TWD 2.34B
Share Statistics
Medimaging Integrated Solution Inc. has 40,233,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 40,233,970
- Owned by Insiders
- ―
- Owned by Institutions
- 0.04%
Financial Efficiency
Medimaging Integrated Solution Inc.’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 0.66%.
- Return on Equity (ROE)
- 0.01
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 0.66%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 4.08M
- Profits Per Employee
- 47.69K
- Employee Count
- 162
- Asset Turnover
- 0.42
- Inventory Turnover
- 1.56
Valuation Ratios
The current PE Ratio of Medimaging Integrated Solution Inc. is 127.75. Medimaging Integrated Solution Inc.’s PEG ratio is -0.15.
- PE Ratio
- 127.75
- PS Ratio
- 3.01
- PB Ratio
- 2.43
- Price to FCF
- -28.07
- Price to Operating Cash Flow
- -51.02
- PEG Ratio
- -0.15
Income Statement
In the last 12 months, Medimaging Integrated Solution Inc. had revenue of 661.39M and earned 7.72M in profits. Earnings per share was 0.20.
- Revenue
- 661.39M
- Gross Profit
- 276.55M
- Operating Income
- 17.92M
- Pretax Income
- 14.65M
- Net Income
- 7.72M
- EBITDA
- 74.50M
- Earnings Per Share (EPS)
- 0.20
Cash Flow
In the last 12 months, operating cash flow was -40.51M and capital expenditures -32.73M, giving a free cash flow of -73.24M billion.
- Operating Cash Flow
- -40.51M
- Free Cash Flow
- -73.24M
- Free Cash Flow per Share
- -1.81
Dividends & Yields
Medimaging Integrated Solution Inc. pays an annual dividend of ―, resulting in a dividend yield of 0.51%
- Dividend Per Share
- ―
- Dividend Yield
- 0.51%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.56%
- Earnings Yield
- 0.69%
Stock Price Statistics
- Beta
- 0.35
- 52-Week Price Change
- -46.16%
- 50-Day Moving Average
- 53.52
- 200-Day Moving Average
- 64.15
- Relative Strength Index (RSI)
- 34.76
- Average Volume (3m)
- 62.94K
Important Dates
Medimaging Integrated Solution Inc. upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Medimaging Integrated Solution Inc. as a current ratio of 2.26, with Debt / Equity ratio of 90.46%
- Current Ratio
- 2.26
- Quick Ratio
- 1.72
- Debt to Market Cap
- 0.17
- Net Debt to EBITDA
- 1.81
- Interest Coverage Ratio
- 1.57
Taxes
In the past 12 months, Medimaging Integrated Solution Inc. has paid 6.92M in taxes.
- Income Tax
- 6.92M
- Effective Tax Rate
- 0.47
Enterprise Valuation
Medimaging Integrated Solution Inc. EV to EBITDA ratio is 31.39, with an EV/FCF ratio of -28.18.
- EV to Sales
- 3.03
- EV to EBITDA
- 31.39
- EV to Free Cash Flow
- -28.18
- EV to Operating Cash Flow
- -50.94
Balance Sheet
Medimaging Integrated Solution Inc. has TWD 617.44M in cash and marketable securities with TWD 453.18M in debt, giving a net cash position of TWD 164.25M billion.
- Cash & Marketable Securities
- TWD 617.44M
- Total Debt
- TWD 453.18M
- Net Cash
- TWD 164.25M
- Net Cash Per Share
- TWD 4.08
- Tangible Book Value Per Share
- TWD 20.41
Margins
Gross margin is 38.93%, with operating margin of -1.07%, and net profit margin of 2.10%.
- Gross Margin
- 38.93%
- Operating Margin
- -1.07%
- Pretax Margin
- 2.99%
- Net Profit Margin
- 2.10%
- EBITDA Margin
- 9.64%
- EBIT Margin
- 1.30%
Analyst Forecast
The average price target for Medimaging Integrated Solution Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 12.26%
- EPS Growth Forecast
- ―
